(Q71598504)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

title

Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference

chronic liver disease

0 references

author name string

A J Czaja

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

H A Carpenter

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

P J Santrach

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

S B Moore

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

publication date

1 January 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

page(s)

52-59

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

HLA Determinants in Chronic Active Liver Disease: Possible Relation of HLA-Dw3 to Prognosis

19 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Increased Frequency of HLA-DRW4 in Chronic Active Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Genetic predispositions for the immunological features of chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Immunologic features and HLA associations in chronic viral hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Primary biliary cirrhosis: current knowledge, perspectives, and future directions

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Current concepts in primary sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Nonalcoholic steatohepatitis: An expanded clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Association of primary sclerosing cholangitis with HLA-B8.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Association of primary sclerosing cholangitis with HLA-DRw52a

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

HLA class II genes in primary sclerosing cholangitis and chronic inflammatory bowel disease: no HLA-DRw52a association in Swedish patients with sclerosing cholangitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

HLA DR4 is a marker for rapid disease progression in primary sclerosing cholangitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Primary biliary cirrhosis: associations with class II major histocompatibility complex antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

HLA DRw8 and complement C4 deficiency as risk factors in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Defining the immunogenetic susceptibility to primary biliary cirrhosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Different immune mechanisms leading to autoimmunity in primary sclerosing cholangitis and autoimmune chronic active hepatitis of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Autoimmune hepatitis. Evolving concepts and treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

A stable sheep cell preparation for detecing thyroglobulin auto-antibodies and its clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Evaluation of a tanned red cell technique for thyroid microsomal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

A DNA-RFLP typing system that positively identifies serologically well-defined and ill-defined HLA-DR and DQ alleles, including DRw10

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Comparison of RFLP-DR beta and serological HLA-DR typing in 1500 individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Nomenclature for factors of the HLA system, 1991.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Cell-mediated immunity and suppressor-T-cell defects to liver-derived antigens in families of patients with autoimmune chronic active hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Autoantibodies during alpha-interferon therapy for chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Hazards of interferon therapy for HBV-seronegative chronic hepatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Autoimmune chronic hepatitis exacerbated by alpha-interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Strong association between HLA-DRW2 and antibody-mediated Goodpasture's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Association of HLA-B8, DRw3, and Anti-Acetylcholine Receptor Antibodies in Myasthenia Gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Hepatitis C virus and autoimmunity: Fortuitous association or reality?

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Early-onset autoimmune hepatitis is associated with a C4A gene deletion.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Polymorphism in the Human Complement C4 Genes and Genetic Susceptibility to Autoimmune Hepatitis

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

Pathogenetic mechanisms of hepatocellular damage in chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2896%2980186-3

7 January 2021

10.1016/S0168-8278(96)80186-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8834025%20AND%20SRC:MED&resulttype=core&format=json

19 October 2019

1 reference